| RS1333709479 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS1333710212 |
NALCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS1333715186 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1333746955 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rubinstein-Taybi syndrome |
| RS1333784125 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS1333791654 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1333793119 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 56, Retinitis pigmentosa 56 |
| RS1333822866 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1333833629 |
PROM1
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 12, Cone-rod dystrophy 12 |
| RS1333865285 |
SETD1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1333876461 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
EP300-related disorder, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1333878137 |
COG4
|
Health Risk |
Pathogenic/Likely pathogenic |
COG4-related disorder, COG4-related disorder |
| RS1333878449 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1333884260 |
AP1G1
|
Health Risk |
Pathogenic |
Usmani-Riazuddin syndrome, autosomal dominant |
| RS1333901047 |
UBR7
|
Health Risk |
Likely pathogenic |
Li-Campeau syndrome, Li-Campeau syndrome |
| RS1333906033 |
ZBED4
|
Health Risk |
Pathogenic |
Short stature, Short stature |
| RS1333914993 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS1333928954 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS1333935838 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1333937435 |
OCRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Lowe syndrome, Dent disease type 2 |
| RS1333983188 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1333985048 |
ABCA4
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS1333990758 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1333994006 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, MCCC1-related disorder |
| RS1334014929 |
ZNF335
|
Health Risk |
Likely pathogenic |
— |
| RS1334033113 |
HSD17B3
|
Health Risk |
Likely pathogenic |
— |
| RS1334033128 |
KDM3B
|
Health Risk |
Pathogenic |
Diets-Jongmans syndrome, Diets-Jongmans syndrome |
| RS1334035467 |
PIGT
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 3, Multiple congenital anomalies-hypotonia-seizures syndrome 3 |
| RS1334038475 |
FUCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fucosidosis, Fucosidosis |
| RS1334057595 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1334081822 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS1334092486 |
WDR19
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS1334099693 |
SOX4
|
Health Risk |
Likely pathogenic |
Mild intellectual disability, Coffin-Siris syndrome 10 |
| RS1334114597 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS1334120731 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS1334127880 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1334134701 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1334138475 |
RSPH1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1334145215 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal dominant polycystic liver disease |
| RS1334148721 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS1334157294 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS1334193252 |
IFT74
|
Health Risk |
Likely pathogenic |
IFT74-related disorder, IFT74-related disorder |
| RS1334199217 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1334243603 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, limb-girdle |
| RS1334244092 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1334301723 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS1334317184 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS1334343532 |
IFT74
|
Health Risk |
Likely pathogenic |
— |
| RS1334349459 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1334355798 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1334366122 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, MYPN-related myopathy |
| RS1334366268 |
NDUFV1
|
Health Risk |
Likely pathogenic |
— |
| RS1334369407 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1334381137 |
BEST1
|
Health Risk |
Likely pathogenic |
Autosomal recessive bestrophinopathy, Autosomal recessive bestrophinopathy |
| RS1334392544 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1334439048 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1334444415 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1334444660 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 56 |
| RS1334468304 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1334483830 |
CEP104
|
Health Risk |
Likely pathogenic |
Joubert syndrome 25, Joubert syndrome 25 |
| RS1334506794 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1334515681 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS1334537145 |
MANBA
|
Health Risk |
Likely pathogenic |
Beta-D-mannosidosis, Ovarian serous cystadenocarcinoma |
| RS1334543067 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1334556134 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS1334577291 |
VRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS1334585480 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Multiple sulfatase deficiency |
| RS1334593208 |
FUT8
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation with defective fucosylation 1, Congenital disorder of glycosylation with defective fucosylation 1 |
| RS1334642659 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Abnormal cortical gyration, Abnormal cortical gyration |
| RS1334651902 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1334656238 |
DAG1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS1334688271 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1334690406 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS1334692966 |
CHD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, CHD8-related disorder |
| RS1334705963 |
NR0B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hypoplasia, X-linked |
| RS1334706550 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1334741748 |
SEC23B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cowden syndrome 7, Congenital dyserythropoietic anemia |
| RS1334767632 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1334775360 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1334776212 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1334776746 |
GABRG2
|
Health Risk |
Pathogenic |
EPILEPSY, CHILDHOOD ABSENCE |
| RS1334781963 |
PGRMC1
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS1334793787 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1334806555 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1334807463 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1334809949 |
VPS13C
|
Health Risk |
Likely pathogenic |
VPS13C-related disorder, VPS13C-related disorder |
| RS1334812460 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1334828764 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1334834057 |
AP1B1
|
Health Risk |
Pathogenic |
Autosomal recessive keratitis-ichthyosis-deafness syndrome, Autosomal recessive keratitis-ichthyosis-deafness syndrome |
| RS1334838296 |
MFF
|
Health Risk |
Pathogenic |
— |
| RS1334843918 |
ATP13A2
|
Health Risk |
Pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS1334848140 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1334882781 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1334888803 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Glycogen storage disease |
| RS1334894971 |
AVIL
|
Health Risk |
Pathogenic |
Steroid-resistant nephrotic syndrome, Nephrotic syndrome |
| RS1334907475 |
F11
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1334913120 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS1334926587 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1334933549 |
PPP3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS1334937558 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |